NCT06654336
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06654336
Title Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) (RATIONAL-PCS)
Acronym RATIONAL-PCS
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Ontario Clinical Oncology Group (OCOG)
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Juravinski Cancer Centre RECRUITING Hamilton Ontario Canada Details
The Ottawa Hospital Regional Cancer Centre NOT_YET_RECRUITING Ottawa Ontario K1H8L6 Canada Details
Jewish General Hospital RECRUITING Montreal Quebec H1T2M4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field